Brian Douglass
Equibles does not estimate personal net worth.
Get an email with a short summary when Repligen Corp publishes a filing, an earnings call transcript or a press release.
Get RGEN alertsAbout Brian Douglass
The proxy statement of Repligen Corp reports total compensation of $1,734,794 for Brian Douglass in fiscal 2025, including a base salary of $417,150. Repligen Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Repligen Corp includes Olivier Loeillot (CEO and Board Member), Dr. Martin D. Madaus (Chairman and Board Member), Martin D. Madaus (Chairman) and 7 others.
Affiliation history
-
Repligen Corp (RGEN)
Proxy statement
CurrentStart not stated–present
Last confirmed April 2, 2026
Company network
Leadership on record at Repligen Corp
- Olivier Loeillot CEO, Board Member
- Dr. Martin D. Madaus Chairman, Board Member
- Martin D. Madaus Chairman
- Tony J. Hunt Chairman
- Jason Garland CFO
- Jason K. Garland CFO, Chief Accounting Officer
- James Bylund COO
- Violetta Hughes Chief Accounting Officer
- Carrie Eglinton Manner Board Member
- Glenn P. Muir Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Repligen Corp (RGEN) | Senior Vice President, Chief Product Officer | $417,150 | $1,734,794 |
Recent activity
No call appearances or filed executive changes recorded yet.